Related Experiment Videos
Central control of bone mass: potential therapeutic implications
Régis Levasseur1, Erick Legrand, Daniel Chappard
1Rheumatology Department and Bone and Joint Center, Angers Teaching Hospital, 4, rue Larrey, 49 933 Angers cedex 9, France. relevasseur@chu-angers.fr
Joint Bone Spine
|November 29, 2005
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Repeated unilateral injections of botulinum toxin in masticatory muscles in adult rats do not amplify condylar and alveolar bone loss nor modify the volume of the hypertrophic bone proliferation at enthesis.
Journal of stomatology, oral and maxillofacial surgery·2024
Differences in bone microarchitecture between genetic and secondary iron-overload mouse models suggest a role for hepcidin deficiency in iron-related osteoporosis.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2023
Development of a First-in-Class Unimolecular Dual GIP/GLP-2 Analogue, GL-0001, for the Treatment of Bone Fragility.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2023
[Gly²]-GLP-2, But Not Glucagon or [D-Ala²]-GLP-1, Controls Collagen Crosslinking in Murine Osteoblast Cultures.
Frontiers in endocrinology·2021
Evaluation of Wound Healing in Wistar Rat Model via Curcumin-Functionalized Copper Nanoparticle Ointment.
Applied biochemistry and biotechnology·2026
Phase 2 test of QBS72S for breast cancer leptomeningeal disease.
Neuro-oncology·2026